人造器官和仿生学市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按类型(人工器官、仿生学)和地理划分

市场快照

global-artificial-organs-bionics-market-industry_Market Summary
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

导致人工器官和仿生学市场增长的主要因素包括残疾和器官衰竭发生率的增加、技术进步以及导致截肢的道路事故的高发率。

另一个主要因素是供体器官的稀缺。缺乏可移植的潜在器官一直是一个主要问题。对器官捐赠者的需求不断增加,与实际供应相比非常高。根据宾夕法尼亚大学 2019 年的一份报告,美国有超过 12 万人在等待移植。这对人工器官仿生市场来说是一个重大推动,因为风险非常高,患者不能排队等候。仿生学和人造器官能够满足需要器官移植和替换的人的需求。它们可以复制受损器官的功能。

然而,诸如担心设备故障、人工器官兼容性风险及其后果等因素可能会影响市场增长。这些植入物也很昂贵,这也是市场增长的制约因素。

报告范围

人造器官是可以暂时或永久替代人体器官的机械装置。人造器官是由人制造的,用活组织植入人体,能够发挥人体各部分的原有功能。仿生学是指通过机械种类替换或改进身体部位。 

By Type
Artificial Organ
Artificial Heart
Artificial Kidney
Artificial Lungs
Cochlear Implants
Other Organ Types
Bionics
Vision Bionics
Ear Bionics
Orthopedic Bionic
Cardiac Bionics
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

肾脏植入物有望占据很大的市场份额

根据疾病控制和诊断中心 2019 年的一份报告,糖尿病是慢性肾病 (CKD) 的最常见原因之一,也是肾衰竭的主要原因。报告中的数据表明,估计患有晚期 CKD(3 或 4 期)的被诊断为糖尿病的成年人的百分比从 1999-2004 年的 19.5% 增加到 2011-2014 年的 24.5%。此外,糖尿病的患病率正在增加。

血液透析是一种去除肌酐和尿素等废物以及当肾脏处于肾功能衰竭时从血液中去除游离水的方法。人工肾用于清洁病人的血液。因此,人工肾的别称也称为透析机。

透析是身体的一项重要功能,包括过滤和排泄代谢废物、调节必要的电解质和体液以及刺激红细胞生成。因此,随着肾衰竭患病率的增加,人工肾的需求也有望增加。

Graph

北美有望主导人造器官和仿生市场

目前,北美在人造器官和仿生学市场上占据主导地位,预计将在未来几年继续占据主导地位。在北美地区,美国占有最大的市场份额。慢性病患病率的上升和对无创外科手术需求的增加正在帮助北美地区在人造器官和仿生学市场上占据主导地位。发达的医疗保健基础设施的存在也有望推动市场。

Geography

竞争格局

大多数人造器官和仿生学都是由全球主要参与者制造的。拥有更多研究资金和更好分销系统的市场领导者已经在市场上确立了自己的地位。此外,由于意识的提高,亚太地区正在出现一些小企业。这也有助于市场的增长。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased Incidence of Disabilities and Organ Failures

      2. 4.2.2 High Incidence of Road Accidents Leading to Amputations

      3. 4.2.3 Scarcity of Donor Organs

      4. 4.2.4 Technological Advancements in the Artificial Organ and Bionics

    3. 4.3 Market Restraints

      1. 4.3.1 Expensive Procedures

      2. 4.3.2 Risk of Compatibility Issues and Malfunctions

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Artificial Organ

        1. 5.1.1.1 Artificial Heart

        2. 5.1.1.2 Artificial Kidney

        3. 5.1.1.3 Artificial Lungs

        4. 5.1.1.4 Cochlear Implants

        5. 5.1.1.5 Other Organ Types

      2. 5.1.2 Bionics

        1. 5.1.2.1 Vision Bionics

        2. 5.1.2.2 Ear Bionics

        3. 5.1.2.3 Orthopedic Bionic

        4. 5.1.2.4 Cardiac Bionics

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 United Kingdom

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South Korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Middle-East and Africa

        1. 5.2.4.1 GCC

        2. 5.2.4.2 South Africa

        3. 5.2.4.3 Rest of Middle East and Africa

      5. 5.2.5 South America

        1. 5.2.5.1 Brazil

        2. 5.2.5.2 Argentina

        3. 5.2.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abiomed Inc

      2. 6.1.2 Asahi Kasei Medical Co., Ltd

      3. 6.1.3 Baxter International, Inc.

      4. 6.1.4 Berlin Heart GmbH

      5. 6.1.5 Boston Scientific Corporation

      6. 6.1.6 Cyberonics Inc.

      7. 6.1.7 Esko Bionics

      8. 6.1.8 Ossur

      9. 6.1.9 Getinge AB

      10. 6.1.10 Medtronic Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Artificial Organs and Bionics Market market is studied from 2018 - 2026.

The Artificial Organs and Bionics Market is growing at a CAGR of 7.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Abiomed Inc, Baxter, Boston Scientific Corporation, Medtronic Inc., Ossur are the major companies operating in Artificial Organs and Bionics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!